Etretinate

Etretinate is a lipid of Prenol Lipids (PR) class. Etretinate is associated with abnormalities such as Psoriasis, Skin lesion, Scleroderma, Chronic graft-versus-host disease and Evaluable Disease. The involved functions are known as Agent, Ulcer and Teratogenesis. Etretinate often locates in Hepatic and Skin. The related lipids are Steroids and Steroid, Systemic.

Cross Reference

Introduction

To understand associated biological information of Etretinate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Etretinate?

Etretinate is suspected in Scleroderma, Chronic graft-versus-host disease, Psoriasis, Skin lesion, Evaluable Disease, Pneumonia, Bacterial and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with Etretinate

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Etretinate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Etretinate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Etretinate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Etretinate?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with Etretinate?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Etretinate

Download all related citations
Per page 10 20 50 100 | Total 1071
Authors Title Published Journal PubMed Link
Gottlieb S et al. Cellular actions of etretinate in psoriasis: enhanced epidermal differentiation and reduced cell-mediated inflammation are unexpected outcomes. 1996 J. Cutan. Pathol. pmid:8915849
Danno K et al. Alterations in ICAM-1 and ELAM-1 expression in psoriatic lesions following various treatments. 1996 J. Dermatol. Sci. pmid:8902653
Altomare G et al. Sweet's syndrome in a patient with idiopathic myelofibrosis and thymoma-myasthenia gravis-immunodeficiency complex: efficacy of treatment with etretinate. 1996 Jan-Feb Haematologica pmid:8900854
Schepers C et al. Papuloerythroderma of Ofuji: a report of 2 cases including the first European case associated with visceral carcinoma. 1996 Dermatology (Basel) pmid:8884150
Maier H and Hönigsmann H Concentration of etretinate in plasma and subcutaneous fat after long-term acitretin. 1996 Lancet pmid:8874484
Pomponi F et al. Retinoids irreversibly inhibit in vitro growth of Epstein-Barr virus-immortalized B lymphocytes. 1996 Blood pmid:8874215
Schmitt-Hoffmann AH et al. Mechanistic studies on the ethyl-esterification of acitretin by human liver preparations in vitro. 1995 Life Sci. pmid:8847958
Panzarella K and Camisa C Coexistence of superficial pemphigus and psoriasis. 1996 Cutis pmid:8804843
Lacour M et al. An appraisal of acitretin therapy in children with inherited disorders of keratinization. 1996 Br. J. Dermatol. pmid:8763418
Van Dooren-Greebe RJ et al. Prolonged treatment with oral retinoids in adults: no influence on the frequency and severity of spinal abnormalities. 1996 Br. J. Dermatol. pmid:8745889